US · Health Claims

Health Claims regulations in US

RegSig maps health claims regulatory intelligence in US to your product portfolio—so compliance teams can proactively manage exposure across authorities, documents, and time horizons.

  • 4 representative signals
  • 3 authorities
  • Usage-based registration

US

Country

Health Claims

Topic

3

Represented authorities

4

Signals shown

Key Health Claims signals for US

Compliance Enforcement on Health Claims Requirements for Compliance Remediation

Near-term

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

FDA Proposed Shift on Health Claims Requirements for FDA-regulated Labels

Near-term

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

FDA Guidance Proposal on Health Claims Requirements for Us Market Labels

Near-term

What changed: Federal regulatory text on this topic was revised, updating labeling, claims, or compliance documentation expectations on affected products.

State Guidance Shift on Health Claims Requirements for State Labeling Programs

Horizon TBD

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

Full signal detail, recommended actions, and portfolio exposure mapping are available after registration.

Authorities referenced in these signals

Explore more topics: Browse Health Claims

Individual access

Monitor Health Claims · US signals in your portfolio

RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.